The purpose of this study was to describe the 30-day incidence of complications after total laryngectomy (TL) in a high-volume institution and their impact on the hospital length of stay (LOS) and readmission rates. METHODS: A retrospective cohort study of all patients who underwent TL at The University of Texas MD Anderson Cancer Center from January 1, 2010 through June 30, 2013 was conducted. The patient demographics, treatment history, LOS, and 30-day post-TL complications and readmissions were extracted from the medical record. Univariate associations were analyzed, and stepwise backward selection methods were used to fit multivariate models. RESULTS: Two hundred forty-five patients were included. Complications occurred in 83 patients (33.9%) and included 3 deaths (1.2%). Wound complications occurred in 53 patients (21.6%), and 34 were pharyngocutaneous fistulas (PCFs; 13.9% overall). Thirty-four patients (13.9%) were readmitted within 30 days. A multivariate analysis revealed the following: wound complications were associated with former (odds ratio [OR], 5.1; P 5.03) and current smokers (OR, 5.8; P 5.02), PCFs were associated with prior wide-field radiation (OR, 3.1; P 5.01) but not prior narrow-field (larynx-only) radiation (OR, 1.4; P 5.61), LOS was associated with the type of flap (P 5.002) and postoperative hematomas (P 5.05), and readmissions were associated with preoperative hypoalbuminemia (P 5.003) and postoperative wound complications (P <.001). CONCLUSIONS: Complications occurred in approximately one-third of TL patients and particularly in patients with poor wound-healing risk factors such as prior smoking and radiation. As expected, LOS was longer among reconstructed patients. Readmission was associated with hypoalbuminemia and postoperative wound complications. These data can inform quality improvement efforts and the counseling of high-risk patients undergoing TL.
INTRODUCTION
The contemporary treatment of advanced laryngeal carcinoma has gradually evolved, in large part because of nonsurgical treatment intensification. However, total laryngectomy (TL) still serves a critical role, whether for the advanced primary tumor, as salvage therapy, or for the previously treated dysfunctional larynx. [1] [2] [3] The need for TL persists for the dysfunctional larynx despite continuing efforts to improve laryngeal cancer outcomes and preserve a functional organ through radiation dose optimization strategies. [4] [5] [6] [7] More commonly, TL remains a primary means of treatment for locally advanced disease and is often the only viable option for a cure in the salvage setting. Yet, there remains a relative paucity of outcome data from large samples of patients treated with TL in the modern era. [8] [9] [10] It is well established that the contemporary cohort of patients undergoing TL is different than many historical cohorts before the era of organ-preservation therapy. 11, 12 Moreover, TL is increasingly concentrated in higher volume academic centers because of a variety of influences, including reimbursement, treatment complexity, and the necessity for multidisciplinary care to achieve optimal outcomes. 13, 14 Lastly, as improved quality of care and resource utilization become clear mandates from public and private payers, institutions, and patients, the ability to anticipate initial treatment outcomes for high-acuity cases such as TL through preoperative risk stratification is increasingly important.
This study was conceived to help to address the need for resource optimization and quality improvement at our own institution, to provide insight into a group of patients amenable to clinical trial interventions aimed at outcome improvement, and to provide insight into the postoperative complications, length of stay (LOS), and readmission rates in a contemporary cohort of TL patients at a high-volume institution.
MATERIALS AND METHODS

Patient Selection and Clinical Variables
This is an institutional review board-approved, retrospective cohort analysis that reviewed the medical records of all consecutive patients who underwent TL at The University of Texas MD Anderson Cancer Center between January 1, 2010 and June 30, 2013 . A waiver of informed consent was obtained. Preoperative clinical variables of interest were collected and included the following: age, sex, cancer stage, primary tumor location and histology, smoking and alcohol history, preoperative albumin and thyroid-stimulating hormone levels, past medical history (including diabetes mellitus and immunosuppression), any prior interventions (eg, preoperative tracheotomy, partial laryngeal surgery, therapeutic radiation, and/or systemic treatment), and reason for TL (ie, primary tumor, salvage treatment, or nonfunctional larynx). Operative details, including the extent of the laryngopharyngeal resection, the completion of the neck dissection (or neck dissections), the method of pharyngeal closure (vertical, horizontal, or T), the use and type of regional or free tissue reconstruction, and the placement of the primary tracheoesophageal prosthesis (TEP), were tabulated. Thirty-day postoperative complications, LOS, and readmissions within 30 days were also reviewed.
Institutional Care Pathways
Although the care of individual patients may vary according to surgeon preference, some postoperative management is standardized by plan-of-care pathways for patients undergoing TL at The University of Texas MD Anderson Cancer Center. Patients undergoing primary TL without flap reconstruction receive perioperative antibiotics for at least 24 hours postoperatively and often start an oral diet on postoperative day 7 with or without a modified barium swallow. Patients requiring flap reconstruction are typically maintained on broad-spectrum antibiotics for at least 7 days and undergo a modified barium swallow 2 weeks or more (depending on the type of reconstruction and previous nonsurgical therapy) before the initiation of an oral diet.
Classification of Variables
Several variables were subjected to further grouping to assist with the analysis and interpretation of data. Primary tumor sites were classified as laryngeal (supraglottic, glottic, and subglottic), pharyngeal (oropharyngeal and hypopharyngeal), or thyroid/other (tracheal and esophageal). Immunosuppression was defined as chronic glucocorticoids, biologic response modifiers, antimetabolites, or immunosuppressive transplant medications at the time of surgery. Patients with prior nonsurgical therapy were divided into the following categories: prior narrow-field radiation (treatment of the larynx only), prior wide-field radiation alone (treatment of the larynx/pharynx and draining lymphatics), and prior wide-field radiation with systemic therapy. The extent of surgical resection was classified as TL alone, TL with partial pharyngectomy and/or glossectomy, and total laryngopharyngectomy (TLP). Wound complications were defined as the development of a pharyngocutaneous fistula (PCF) or cellulitis, a neck abscess, or neck incisional dehiscence in the absence of evidence indicating a salivary leak. Lastly, hypoalbuminemia and hypothyroidism were defined according to institutional clinical laboratory thresholds for albumin (<3.5 g/ dL) and thyroid-stimulating hormone (>4.2 mIU/mL), respectively.
Statistical Analysis
Patient characteristics, tumor characteristics, prior/current treatment characteristics, complications, LOS, and readmission variables were summarized with descriptive statistics. Covariates exhibiting significant associations with complications, LOS, and readmission were identified initially with a univariate analysis. Multivariate regression models were fit with a backwards stepwise method for variable entry and removal. 15 Covariates that attained a P value < .20 were subsequently considered for multiple logistic and linear regression analysis for complications or readmission and LOS, respectively. A P value < .05 conferred statistical significance. Final results are reported with the set of covariates that attained statistical significance in the multiple regression analysis. Statistical analyses were performed with Stata 14.0 data analysis software (StataCorp LP, College Station, Texas).
RESULTS
Patients and Prior Treatment
Two hundred forty-five patients were included in the analysis. Table 1 lists patient demographics, tumor specifics, prior cancer treatments, and relevant past medical histories. The mean age was 64.1 years, 79% were male, and 70% had primary tumors in the larynx. Preoperatively, 20% of the patients had hypothyroidism, 32% had hypoalbuminemia, and 29% had diabetes mellitus and/or were immunosuppressed. Fifty-six percent were former smokers, and 30% were current smokers. Sixty-two percent of the patients had previously undergone radiation therapy (narrow-field radiation for 26% and wide-field radiation for 74% with or without concurrent chemotherapy).
Patients with prior radiation therapy were an average of 4.3 years (mean, 2.1 years) from the completion of their treatment at the time of surgery. Sixty-seven percent of the patients had either regional or free tissue transfer reconstruction, and 73% of these patients had prior radiation therapy. Twenty patients were treated with neoadjuvant chemotherapy before primary TL; 85% of the patients (79 of 93) undergoing primary TL had T4 tumors.
Operative Details
Ninety-three patients (38%) underwent TL for primary cancer treatment, 137 patients (56%) underwent salvage procedures, and 15 laryngectomies (6.1%) were performed for chronic laryngeal dysfunction secondary to prior organ-preservation therapy; 43.7% had TL alone without partial or total pharyngectomy, and 85.7% had concurrent neck dissection. Among all patients, 67% underwent reconstruction with regional or free tissue transfer; this included 20 pectoralis major flaps (17 were onlay), 124 anterolateral thigh flaps, 10 radial forearm flaps, and 10 other flaps (including 3 jejunal flaps). Five patients had more than 1 free flap for the reconstruction of complex defects. Among patients with prior radiation therapy, 54% of narrow-field patients and 88% of widefield patients underwent flap placement at the time of the initial pharyngeal closure or reconstruction. Primary TEP placement was performed for 80 patients (33%), who included 21 patients undergoing the procedure at the same time as flap reconstruction (or 12.7% of flap cases). See Table 2 for a summary of operative characteristics.
Overall Complications and Treatment Required
Overall, 144 complications, including 3 deaths (1.2%), occurred in 83 patients (34% ; Table 3 ). PCFs, nonfistulous wound complications, and hematomas were most common. Eleven patients were treated for pneumonia during their postoperative hospitalization, and 4 developed a chyle leak. Nine patients developed less common complications, including myocardial infarction (n 5 1), a syndrome of inappropriate antidiuretic hormone secretion (n 5 2), and severe postoperative hypoparathyroidism requiring a temporary intravenous calcium infusion (n 5 1). Among the treatments for overall complications, 58 patients received antibiotics, 51 required additional surgical procedures, and 14 received additional wound care without a return to the operating room. The majority of the patients (38 of 51) who required a return to the operating room did so for a washout and/or closure revision. The remaining 13 patients required additional reconstruction (10 pectoralis major flaps and 3 free flaps); 5 of these patients were primarily closed initially. Four of these patients were salvage cases. Univariate analysis results for overall complications are listed in Tables 1 and  2 . A multivariate analysis determined that prior laryngeal surgery was associated with a decreased likelihood of overall complications (odds ratio, 0.27; 95% confidence interval [CI]; 0.09-0.82), whereas patients undergoing more extensive resections, namely TLP, had a statistically significantly increased likelihood of overall complications (odds ratio, 1.44; 95% CI; 1.02-2.03).
Wound Complications
Wound complications (PCF or nonfistulous complications of cellulitis, neck abscess, or neck incisional dehiscence) occurred in 53 patients. Ten patients developed cellulitis, 4 had neck abscesses, and 13 experienced dehiscence of their neck incision in the absence of a recognized salivary fistula. Considering wound complications on the whole, a univariate analysis revealed that the extent of surgical resection, need for reconstruction, smoking history, and prior radiation therapy were associated with increased odds of these outcomes. Preoperative tracheotomy and primary TEP placement were negatively associated with wound complications. In a multivariate analysis, only a prior smoking history, including both former and current smokers, maintained a statistical association; the likelihood of wound complications was increased 5.1 (95% CI, 1.1-22.4) and 5.8 times (95% CI, 1.3-26.5), respectively ( Fig. 1) .
PCF
PCFs occurred in 34 patients (13.9%): 97% were managed with antibiotics, 56% received local wound care, and 23 patients (68%) returned at least once to the operating room. Although a return to the operating room was common overall, it was not more likely in flap patients. An increased risk for a PCF in a univariate analysis was found among former and current smokers, patients with prior radiation therapy, patients with primary tumors in the pharynx as well as those undergoing TLP, and patients requiring flap reconstruction. There were no significant differences in fistulas between no reconstruction and flap reconstruction among salvage cases. Again, preoperative tracheotomy and primary TEP were associated with decreased odds of a salivary fistula. A multivariate analysis demonstrated that patients with prior wide-field radiation but not narrow-field radiation were 3.1 times more likely (95% CI, 1.3-7.7) to develop a PCF than those without prior radiation (Fig. 1 ). Prior treatment with concurrent chemotherapy did not increase the risk for a fistula in comparison with wide-field radiation alone.
LOS
The average hospitalization was 8.1 days (median, 7 days; range, 3-27 days). Patients undergoing TL for laryngeal dysfunction had the shortest mean stay at 7.1 days, and they were followed by patients undergoing primary TL (8.0 days) and salvage TL (8.3 days); however, the median LOS was 7 days for all. For flap-reconstructed patients, the mean LOS was 8.8 days (median, 8 days), whereas the mean was 6.6 days (median, 6 days) for those not requiring flaps. A univariate analysis found the extent of surgical resection and the type of flap to be associated with a longer LOS. Wound complications (fistulas in particular) and hematomas were also associated with extended hospitalization. A multivariate analysis including all significant covariates revealed that the type of flap (P 5 .002) and hematomas (P 5 .05) predicted a longer LOS. Examining flap patients more closely, we found that patients with pectoralis major reconstructions had the shortest LOS, and they were followed by patients with anterolateral thigh flaps, radial forearm flaps, and, lastly, other flaps (P 5 .001; Fig. 2 ). Patients with a postoperative hematoma stayed in the hospital almost 3 days longer on average than those not developing a hematoma (10.7 vs 7.8 days, respectively; P 5 .0004). Because of the impact of developing a hematoma on LOS, an additional univariate analysis revealed that salvage surgery (and prior radiation therapy), a pharyngeal tumor site, and a need for flap reconstruction were statistically significant, although none of these associations maintained statistical significance in a multivariate model.
Readmission
Thirty-four patients (13.9%) were readmitted to the hospital within 30 days of discharge. A univariate analysis demonstrated that current and former smokers, patients with hypoalbuminemia, and patients who developed wound complications (fistulas in particular) or pneumonia were more likely to require readmission. Patients who had undergone preoperative tracheotomy and patients with diabetes or immunosuppression were negatively associated with readmission. A multivariate analysis revealed patients with wound complications (P < .001) as well as those with low albumin levels preoperatively (P 5 .003) to be highly associated with readmission ( Fig.  1 ). More specifically, 22% of the patients with preoperative hypoalbuminemia and 51% of the patients who developed postoperative wound complications required readmission within 30 days. Readmitted patients had an average preoperative albumin level of 3.4 g/dL (median, 3.3 g/dL), whereas the average was 3.7 g/dL (median, 3.9 g/dL) for those who remained outpatients (P 5 .01).
DISCUSSION
These patients undergoing TL at a single high-volume institution during a relatively short interval represent a contemporary cohort that had either prior nonsurgical therapy with persistent/recurrent cancer or chronic laryngeal dysfunction or a large and/or functionally limiting primary tumor at presentation. Almost two-thirds of the patients had prior radiation therapy, and the vast majority without prior radiation therapy (85%) had stage T4 primary tumors. Complications occurred in roughly onethird of the patients and included wound complications (incidence, 21.6%) and PCFs (incidence, 13.8%). LOS was highly associated with the development of postoperative hematomas and with the flap type for patients who required additional reconstruction in excess of a primary pharyngeal closure. Lastly, readmission was significantly associated with low albumin levels and the development of wound complications. Wound complications (specifically PCFs) and hematomas are well recognized as the most common complications in primary and salvage TL. [16] [17] [18] This study found a strong association between wound complications and both current and former smokers, and its findings support prior evidence linking smoking to overall complications and PCFs in TL. 19 Despite the clinically apparent negative impact of smoking on wound healing, a recent systematic analysis of smoking and perioperative complications in head and neck cancer found mixed results, largely because of the heterogeneity of the studies in terms of methodology, smoking classification, and outcomes of interest. Nevertheless, this association is supported by strong physiologic plausibility and evidence of relative tissue hypoxemia in current and/or recent smokers as well as knowledge of common comorbidities among smokers that negatively affect wound healing. 20, 21 In the absence of biochemical confirmation of smoking cessation, it is true that these groups may be subject to misclassification. Because both former and current smokers were at increased risk, this further bolsters efforts to support smoking cessation before both surgical and nonsurgical treatment not only because smoking in the latter group influences treatment toxicity and efficacy but also because these patients may eventually require a salvage procedure.
Many studies have documented an association between PCFs and prior radiation. [22] [23] [24] In an era when the type and location of prior radiation therapy are of paramount importance for treatment decision making, few studies examining post-TL complications have made a distinction between the narrow radiation fields used for early glottic cancers and the wider fields used for more advanced glottic tumors or those in other laryngeal and pharyngeal locations. 25 Although population-level studies and meta-analyses may also be limited in their ability to derive this granular information, publications reporting an association between PCFs and prior chemoradiation or extralaryngeal primary tumor sites can likely be assumed to have included patients with prior wide-field treatment, as was found in this study. 17, 26, 27 Indeed, this finding strongly reinforces the argument that specifics of nonsurgical treatment (particularly prior radiation therapy in excess of a narrow-field approach) must be considered for surgical planning and counseling for patients requiring salvage TL. The time since the completion of radiation was not significantly associated with the outcomes of interest. Nevertheless, these radiation data suggest the need to distinguish narrow-field radiotherapy failures as more favorable when we are attempting to risk-stratify patients for PCFs because this group did not have a significantly elevated risk for PCFs despite approximately 35% less use of flap reconstruction. Alternatively, it may be argued that this lack of difference in fistula rates is influenced by the selection bias due to a surgeon's impression for the initial need of flap reconstruction and cannot be explained through a retrospective study.
Because of the high morbidity of PCFs, salvage TL represents one of the most common indications within head and neck surgery for regional or free tissue reconstruction. 14, [28] [29] [30] The use of vascularized tissue reconstruction of the neopharynx, even in an onlay fashion, has greatly reduced the incidence of PCFs and wound complications. 18, [31] [32] [33] In agreement with this trend, more than two-thirds of the patients in this study underwent reconstruction with regional or free tissue transfer. Considering complication outcomes by the type of reconstruction, we found no statistically significant differences, but this must be interpreted with the understanding that the vast majority of reconstructions were anterolateral thigh flaps. Pectoralis flaps were mainly reserved for 2 scenarios: a need to bolster closure in the salvage setting where the pharyngeal mucosa is entirely spared and/or a free tissue transfer is deemed too risky from an operative-risk standpoint. An analysis of patient hospitalization showed an association with incremental increases in LOS by flap type; this finding is supported by other publications and clinical practice. 34 LOS must be considered in the context of departmental and institutional characteristics such as case volume and plan-of-care pathways. Such pathways have been shown to be beneficial from the standpoints of LOS, complications, and readmission in several groups of postsurgical head and neck cancer patients, including TL patients. 13, [35] [36] [37] [38] Readmission rates were predictably higher among patients who developed wound complications, including patients who had wound complications identified and treated during their initial hospitalization. Prior population-level and single-institution studies have documented similar findings. 39, 40 Unfortunately, a retrospective study is unable to provide insight into the nuances of hospitalizations and possible decision-making processes that might explain readmissions (or premature discharges) for individual patients or groups of patients. Our study did reveal that preoperative hypoalbuminemia was associated with 2.8 times greater odds of readmission. Prior studies have found an association between low preoperative albumin levels (or preoperative dietary counseling) and wound complications, and this aligns well with our findings and provides a measureable, actionable item for optimizing outcomes and reducing readmission rates. 23, 41, 42 Because the preoperative nutritional status represents a potentially modifiable risk factor, this study argues that the formal involvement of a clinical dietitian for nutritional optimization should also be a common part of the multidisciplinary care of TL patients preoperatively rather than ad hoc for those who have the most obvious malnourishment.
The primary limitation of this study rests in its retrospective design, which predisposes data to possible differential misclassification and may bias results either toward or away from the null. Also, because of the nature of the data collection and the specifics of the electronic medical record, details on the duration and type of antibiotic prophylaxis or treatment, the severity of complications such as PCFs, and unrecognized contributing factors that may have led to prolonged hospitalization or readmission for individual patients could not be taken into account. Because our institution has a large referral base from both surgical and nonsurgical providers, details on prior treatments, including the exact radiation dose, timing, and type of systemic therapy, were not always available, and this meant that the analysis also could not be conducted to this degree of specificity. Nevertheless, given the patient volume at a single institution and the relatively short interval in comparison with many other publications, this study was able to minimize surgical heterogeneity and improve generalizability for a modern cohort of TL patients and was adequately powered for a multivariate analysis adjusted for potential confounding factors that influence postoperative complications, LOS, and readmission.
These data constitute valuable evidence on the use of TL in the era of organ preservation, can be used to enhance surgical quality improvement efforts through outcome optimization, and show the need for evidence-based risk stratification as increasing emphasis is placed on shared decision making and resource utilization.
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